Lynx1 Capital Management LP
CIK 1910456 · Holdings on Dec 31, 2023 · First reported Feb 14, 2024
Top ten holdings
Q4 2023- NVLS28.58%
- CABA18.84%
- MRUS12.28%
- TCRX11.98%
- CCCC6.96%
- STOK6.12%
- AUTL4.71%
- GHRS4.19%
- KNTE1.86%
- SLN1.61%
Share classes counted separately97.13%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- NVLSWeight increased · +10.37 pp18.21% → 28.58%Shares +1.41M (+58.61%)
- CCCCWeight increased · +5.71 pp1.25% → 6.96%Shares +2.12M (+207.53%)
- MRUSWeight decreased · -5.66 pp17.94% → 12.28%Shares -15.00K (-1.30%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 15
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | NVLSALPINE IMMUNE SCIENCES INC View history and evidence | $72.69M | 28.58% | 3.81M shares | 18.21% → 28.58%+10.37 pp +1.41M (+58.61%) | Added | ↗▾ |
| 02 | CABACABALETTA BIO INC View history and evidence | $47.91M | 18.84% | 2.11M shares | 21.20% → 18.84%-2.36 pp +4.40K (+0.21%) | Added | ↗▾ |
| 03 | MRUSMERUS NV View history and evidence | $31.22M | 12.28% | 1.14M shares | 17.94% → 12.28%-5.66 pp -15.00K (-1.30%) | Reduced | ↗▾ |
| 04 | TCRXTSCAN THERAPEUTICS INC View history and evidence | $30.46M | 11.98% | 5.22M shares | 8.85% → 11.98%+3.13 pp 0 (0.00%) | Unchanged | ↗▾ |
| 05 | CCCCC4 THERAPEUTICS INCCOM STK View history and evidence | $17.71M | 6.96% | 3.13M shares | 1.25% → 6.96%+5.71 pp +2.12M (+207.53%) | Added | ↗▾ |
| 06 | STOKSTOKE THERAPEUTICS INC View history and evidence | $15.55M | 6.12% | 2.96M shares | 4.46% → 6.12%+1.66 pp +1.25M (+72.90%) | Added | ↗▾ |
| 07 | AUTLAUTOLUS THERAPEUTICS PLCSPON ADS View history and evidence | $11.97M | 4.71% | 1.86M shares | 2.10% → 4.71%+2.61 pp +495.38K (+36.34%) | Added | ↗▾ |
| 08 | GHRSGH RESEARCH PLCORDINARY SHARES View history and evidence | $10.66M | 4.19% | 1.84M shares | 7.33% → 4.19%-3.14 pp +735.44K (+66.67%) | Added | ↗▾ |
| 09 | KNTEKINNATE BIOPHARMA INC View history and evidence | $4.73M | 1.86% | 2.00M shares | 1.85% → 1.86%+0.01 pp 0 (0.00%) | Unchanged | ↗▾ |
| 10 | SLNSILENCE THERAPEUTICS PLC-ADRADS View history and evidence | $4.10M | 1.61% | 235.79K shares | 1.53% → 1.61%+0.08 pp 0 (0.00%) | Unchanged | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 3
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| CBAY CYMABAY THERAPEUTICS INC | Non-derivative | -994,161 | -$14.82M | SEC filing ↗ | SEC filing ↗ |
| ZURA ZURA BIO LTD | Non-derivative | -9,917 | -$65.45K | SEC filing ↗ | SEC filing ↗ |
| DBVT DBV TECHNOLOGIES SA-SPON ADR | Non-derivative | -18,265 | -$24.84K | SEC filing ↗ | SEC filing ↗ |
3 / 3 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1910456 · Period 2023-12-31
Data loaded 2026-09-23 · First reported 2024-02-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 254317926
}Take these holdings further.
This page includes 15 of 15 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 15 of 15 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1910456","quarter":"2023Q4","page_size":100}
get_institutional_manager_history
{"cik":"1910456","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.